Three senior leaders reappointed for five-year terms
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved five-year reappointments for Dr Abhinay Bollineni as Director and CEO from January 18, 2027; Dr Bhaskara Rao Bollineni as Chairman and Managing Director from April 1, 2027, continuing beyond age 70; and Dandamudi Anitha as Whole-time Director from April 1, 2027.
The reappointments support leadership continuity and do not represent a management change or a new executive appointment.